Log In
Print
BCIQ
Print
Print this Print this
 

Fc-EDA1 (EDI200)

Also known as: formerly APO200

  Manage Alerts
Collapse Summary General Information
Company Edimer Pharmaceuticals Inc.
DescriptionRecombinant protein comprised of the Fc domain of human IgG1 and the tumor necrosis factor (TNF) domain of the ectodysplasin A gene (EDA1)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase II
Standard Indication Dermatology (unspecified)
Indication DetailsTreat X-linked hypohydrotic ectodermal dysplasia (XLHED)
Regulatory Designation

U.S. - Fast Track (Treat X-linked hypohydrotic ectodermal dysplasia (XLHED))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today